Analgesic
Indomethacin
search
Indomethacin
, Indocin
See Also
Nonsteroidal Anti-inflammatory
Indications
FDA Approved
Adults
Rheumatoid Arthritis
Osteoarthritis
Acute
Gouty Arthritis
Ankylosing Spondylitis
Children
Patent Ductus Arteriosus
in the newborn
Indications
Off-Label (Not FDA approved)
Adults
Pericarditis
Bartter's Syndrome
Cluster Headache
Preterm Labor
(
Tocolysis
)
Polyhydramnios
Primary Dysmenorrhea
Children
Juvenile Rheumatoid Arthritis
Contraindications
Peptic Ulcer Disease
Aspirin
Sensitivity
Renal Disease
Coagulopathy
Pregnancy beyond 30 weeks
Childhood (except
Patent Ductus Arteriosus
)
Dementia
Mechanism
NSAID
in the acetic acid class (indole)
Pharmacokinetics
Half life: 2 hours
Medications
Immediate Release Capsules: 25 mg, 50 mg
Sustained Release Capsules: 75 mg
Do not open or crush sustained release capsules
Oral suspension: 25 mg/5 ml
Suppository: 50 mg
Only
NSAID
available in suppository form
Dosing
Adults
Precautions
Limit to lowest effective dose and for least time needed
See other references for dosing and indications for use in polyhydramnios
Immediate Release
Typical dosing range (acute musculoskeletal pain,
Dysmenorrhea
)
Start 25 mg orally three times daily with food or milk
May advance to 50 mg orally three times daily if needed
Arthritis
(RA, OA)
Start: 25 mg orally twice to three times daily
May advance to 150 to 200 mg/day divided three to four times daily)
Acute
Gouty Arthritis
Start 50 mg orally three times daily for 2 to 3 days (until pain is controlled)
Next 25 mg orally three times daily for 7 to 10 days
Sustained Release (
Cluster Headache
, acute
Gouty Arthritis
)
Dose 75 mg orally daily to twice daily
Maximum: 200 mg/day (divided three to four times daily)
Dosing
Children
Juvenile Rheumatoid Arthritis
(not FDA approved)
Start 1 to 3 mg/kg/day divided 3 to 4 times daily
May advance as needed to 4 mg/kg/day (up to max: 200 mg/day)
Dosing
Preterm Labor
Precautions
Associated with risk of significant maternal and fetal complications when used in
Preterm Labor
(see below)
Confirm with other references and consult maternal fetal medicine before using Indomethacin in pregnancy
Protocol 1
Loading dose: 100 mg suppository rectally
Maintenance: 25 mg PO every 6 hours for 24 hours
Repeat for an additional 24 hours maximum
Protocol 2
Loading dose: 50 mg PO
Maintenance: 25 mg PO every 4 hours for 24 hours
Repeat for an additional 24 hours maximum
Monitoring
Amniotic Fluid Index biweekly for use >48 hours
Adverse Effects
Gene
ral (more than other
NSAID
s)
See
NSAID
See
NSAID Gastrointestinal Adverse Effects
See
NSAID Renal Adverse Effects
Headache
Peptic Ulcer
Gastrointestinal upset
Fluid retention
Prolonged
Bleeding Time
Nausea
or
Vomiting
Pruritus
Bowel
changes
Mood disturbance
May worsen
Major Depression
Nephrotoxic
See
Nephrotoxicity due to NSAIDs
Adverse Effects
Maternal and Fetal
See
NSAID
Maternal effects
Postpartum Hemorrhage
Fetal effects
Early ductus arteriosus closure
Fetal
Pulmonary Hypertension
Oligohydramnios
Not linked to Intraventricular
Hemorrhage
Suarez (2001) Obstet Gynecol 97:921-5 [PubMed]
Safety
Considered safe in
Lactation
Avoid
NSAID
s in pregnancy outside the first part of the second trimester (13 to 20 weeks)
Teratogen
ic in first trimester
Risk of premature ductus arteriosus closure in the fetus in third trimester
Most
NSAID
s carry a legacy system Pregnancy Category B or C designation (aside from third trimester)
However, many obstetricians avoid
NSAID
s entirely in pregnancy (even in second trimester)
Drug Interactions
Lithium
Efficacy
Most potent
NSAID
(however this carries renal and GI risks)
Resources
Indomethacin (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ce9c3c5-0cf7-4760-988d-2559adcfb200
Indomethacin (StatPearls)
https://www.ncbi.nlm.nih.gov/books/NBK555936/
References
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here